FDA Person
FDAUttaniti Limchumroon
View detailed information about Uttaniti Limchumroon, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Uttaniti Limchumroon, including their role, qualifications, and regulatory activities.
Recent Records (32)
Page 1 of 2RESUME - Unknown Company
RESUME
483 - Barclay, Luke, & Pillai Specialty Pharmacy, PLLC
483
483 - BMD Skincare, Inc.
483
483 - Inventive Infusion Solutions, LP
483
483 - ABC Pharmaceuticals
483
483 - Auro Pharmacies, Inc DBA Central Drugs
483
483 - Kohana Pharmacy and Center for Regenerative Medicine Inc.
483
483 - Auro Pharmacies, Inc DBA Central Drugs
483
483 - Dignity Health - Northridge Hospital Medical Center
483
483 - Auro Pharmacies, Inc.
483
483 - Dignity Health - Northridge Hospital Medical Center
483
483 - Barclay, Luke, & Pillai Specialty Pharmacy, PLLC
483
483 - Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
483
483 - Inventive Infusion Solutions, LP
483
483 - Advanced Botanical Consulting & Testing, LLC
483
EIR - PolyPeptide Laboratories, Inc.
EIR
EIR - Gilead Sciences, Inc.
EIR
EIR - PETNET Solutions, Inc.
EIR
483 - Hubei Gedian Humanwell Pharmaceutical Co., Ltd.
483
483 - Dasami Lab Private Limited
483
Showing 1-20 of 32 records
Person Information
Name
Uttaniti Limchumroon
Role
Regulatory Personnel
ID: ce890cbf-2f5c-498f-917c-0edf8b10d356
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox